Related Experiment Video

Updated: Aug 8, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

[Kawasaki's disease, current concepts of coronary revascularization surgery in the pediatric poblation]

Jorge Luis Cervantes-Salazar1, Juan Calderón-Colmenero, José A García-Montes

  • 1Servicio de Cirugía de Cardiopatías Congénitas, Instituto Nacional de Cardiología Ignacio Chávez", (INCICH, Juan Badiano No. 1, 5to Piso, Col. Sección XVI, Tlalpan 14080 México, DF. jlcersa@yahoo.com.mx

Archivos De Cardiologia De Mexico
|June 6, 2006
PubMed

Insights

Kawasaki disease is a leading cause of pediatric acquired heart conditions, often leading to coronary artery stenosis. Improved understanding and adult-based treatments are enhancing pediatric care for this condition.

Area of Science:

  • Pediatric Cardiology
  • Immunology
  • Vascular Biology

Background:

  • Kawasaki disease is the primary cause of acquired pediatric heart conditions in many nations, surpassing rheumatic fever.
  • Coronary artery abnormalities, particularly stenosis, are the most frequent complication of Kawasaki disease.

Observation:

  • Treatment protocols for acute and chronic coronary events in children are adapted from adult medical knowledge.
  • Growing clinical experience with pediatric Kawasaki disease has refined management and therapeutic strategies.

Findings:

  • Kawasaki disease significantly contributes to pediatric acquired cardiopathies.
  • Coronary artery stenosis is a prevalent and serious complication.

Implications:

  • Further research into Kawasaki disease pathophysiology may yield novel targeted therapies.
  • Enhanced understanding of adult coronary disease management can be translated to pediatric cases, improving patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...